Independence Energy Corp (IDNG) app.quotemedi
Post# of 242
(Total Views: 1141)
Posted On: 07/28/2019 1:36:35 PM
Independence Energy Corp (IDNG)
https://www.otcmarkets.com/filing/html?id=135...EX99-1_HTM
IDNG names Dr Drew as national spokesperson . Fda approved product to launch in school systems
https://drdrew.com
About RedHawk Holdings Corp.
RedHawk Holdings Corp., formerly Independence Energy Corp., is a diversified holding company which, through its subsidiaries, is engaged in sales and distribution of medical devices, sales of branded generic pharmaceutical drugs, commercial real estate investment and leasing, sales of point of entry full-body security systems, and specialized financial services.
Through its medical products business unit, the Company sells the Sharps and Needle Destruction Device (SANDD™)http://www.needledestructiondevice.com
WoundClot Surgical - Advanced Bleeding Control, and the Carotid Artery Digital Non-Contact Thermometer.
http://www.woundclot.com/?product=woundclot-surgical-ce-iii
Through our United Kingdom based subsidiary, we manufacture and market branded generic pharmaceuticals.
RedHawk Energy holds the exclusive U.S. manufacturing and distribution rights for the Centri Controlled Entry System, a unique, closed cabinet, nominal dose transmission full-body x-ray scanner
List of subsidiaries:
IDNG/REDHAWK:
RedHawk Medical Products & Service
RedHawk Medical Products
http://redhawkmedical.co.uk
RedHawk Pharma, LLC
EcoGen
https://ecogen-europe.co.uk
Centri Security Systems, LLC .
Centri Controlled Entry System, a unique, closed cabinet, nominal dose transmission full-body x-ray scanner
http://redhawkenergycorp.com/
Name change soon $HAWC
http://www.redhawkholdingscorp.com/
"Agreement with Jeeds Health , Inc., an affiliate of Pharmaceutical Buyers, Inc. ( "PBI" - www.pharmaceuticalbuyersinc.com ), for the sale of its SANDD..
PBI, a New York-based company headquartered in Long Island, New York, sources and distributes clinical trial, biologic and specialty drugs to approximately 285 major pharmaceutical and biotech companies in the United States and overseas. "
NEWS: 6/24/2-19 8K - Debt eliminated: Holders of $574,250 aggregate principal amount of the Company’s 5% convertible promissory notes (“Notes”), including accrued interest, have converted their Notes into 114,849,929 shares of Common Stock
6/24/2-19 8K - Warrants at half a cent: Beechwood now holds a Stock Purchase Warrant (“Warrant”) to acquire 113,508,450 shares of Common Stock at an exercise price of $0.005 per share. The Warrant expires June 20, 2029.
http://www.prweb.com/releases/redhawk_increas...276234.htm
Needle destruction device approved by the United States Food and Drug Administration (“ FDA ”) for home use. The acquired assets included, but was not be limited to, all matters subject to the SANDD™ original patent applications, including technical designs, drawings, trademarks, tradenames, FDA documents, clinical test data, and all manufacturing tooling and fixtures.
Approved for self-injectors at home in the State of California.
Home and commercial applications including hospitals, first responders, a full range of clinics and primary care physicians, dentists, veterinarians, retirement and non-acute healthcare facilities.
it is estimated that 600,000 to 1,000,000 healthcare personnel alone incur a needlestick injury each year in the U.S. 40% of injuries occur after use and before disposal of sharp devices
" within the next thirty (30) days, we plan to commence deliveries of the SANDD mini™ into the Texas school systems. ." June 13,2019 PR $IDNG
https://www.stockscores.com/chart.asp?TickerS...s=redgreen
https://www.otcmarkets.com/stock/IDNG/security
https://www.otcmarkets.com/filing/html?id=135...EX99-1_HTM
IDNG names Dr Drew as national spokesperson . Fda approved product to launch in school systems
https://drdrew.com
About RedHawk Holdings Corp.
RedHawk Holdings Corp., formerly Independence Energy Corp., is a diversified holding company which, through its subsidiaries, is engaged in sales and distribution of medical devices, sales of branded generic pharmaceutical drugs, commercial real estate investment and leasing, sales of point of entry full-body security systems, and specialized financial services.
Through its medical products business unit, the Company sells the Sharps and Needle Destruction Device (SANDD™)http://www.needledestructiondevice.com
WoundClot Surgical - Advanced Bleeding Control, and the Carotid Artery Digital Non-Contact Thermometer.
http://www.woundclot.com/?product=woundclot-surgical-ce-iii
Through our United Kingdom based subsidiary, we manufacture and market branded generic pharmaceuticals.
RedHawk Energy holds the exclusive U.S. manufacturing and distribution rights for the Centri Controlled Entry System, a unique, closed cabinet, nominal dose transmission full-body x-ray scanner
List of subsidiaries:
IDNG/REDHAWK:
RedHawk Medical Products & Service
RedHawk Medical Products
http://redhawkmedical.co.uk
RedHawk Pharma, LLC
EcoGen
https://ecogen-europe.co.uk
Centri Security Systems, LLC .
Centri Controlled Entry System, a unique, closed cabinet, nominal dose transmission full-body x-ray scanner
http://redhawkenergycorp.com/
Name change soon $HAWC
http://www.redhawkholdingscorp.com/
"Agreement with Jeeds Health , Inc., an affiliate of Pharmaceutical Buyers, Inc. ( "PBI" - www.pharmaceuticalbuyersinc.com ), for the sale of its SANDD..
PBI, a New York-based company headquartered in Long Island, New York, sources and distributes clinical trial, biologic and specialty drugs to approximately 285 major pharmaceutical and biotech companies in the United States and overseas. "
NEWS: 6/24/2-19 8K - Debt eliminated: Holders of $574,250 aggregate principal amount of the Company’s 5% convertible promissory notes (“Notes”), including accrued interest, have converted their Notes into 114,849,929 shares of Common Stock
6/24/2-19 8K - Warrants at half a cent: Beechwood now holds a Stock Purchase Warrant (“Warrant”) to acquire 113,508,450 shares of Common Stock at an exercise price of $0.005 per share. The Warrant expires June 20, 2029.
http://www.prweb.com/releases/redhawk_increas...276234.htm
Needle destruction device approved by the United States Food and Drug Administration (“ FDA ”) for home use. The acquired assets included, but was not be limited to, all matters subject to the SANDD™ original patent applications, including technical designs, drawings, trademarks, tradenames, FDA documents, clinical test data, and all manufacturing tooling and fixtures.
Approved for self-injectors at home in the State of California.
Home and commercial applications including hospitals, first responders, a full range of clinics and primary care physicians, dentists, veterinarians, retirement and non-acute healthcare facilities.
it is estimated that 600,000 to 1,000,000 healthcare personnel alone incur a needlestick injury each year in the U.S. 40% of injuries occur after use and before disposal of sharp devices
" within the next thirty (30) days, we plan to commence deliveries of the SANDD mini™ into the Texas school systems. ." June 13,2019 PR $IDNG
https://www.stockscores.com/chart.asp?TickerS...s=redgreen
https://www.otcmarkets.com/stock/IDNG/security
(0)
(0)RedHawk Holdings Corp. (SNDD) Stock Research Links
HPMM PCLI ZMRK OXIHF IKTO VGLS RMRK APRU NWPN SNRY MEDH